Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by GoBBson Apr 11, 2020 4:16pm
95 Views
Post# 30899366

RE:RE:RE:RE:RE:RE:RE:Time will tell and the clock is ticking on H1 2020

RE:RE:RE:RE:RE:RE:RE:Time will tell and the clock is ticking on H1 2020your clearly not one of the hundreds of investors who are part of the lawsuit ...but you agree with what they did anyway because they needed to restructure ...right ?

You were there, many of us believed in these people ... many things were said, many things were and were not done ...it will play out in court when the layers are ready, trust me. On Ryplazim most have no issue which is why we were there.
<< Previous
Bullboard Posts
Next >>